欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1336/004
药品名称
Ramipril/Amlodipine Adamed 10 mg/5 mg
活性成分
amlodipine besilate 10.0 mg
ramipril 5.0 mg
剂型
Capsule, hard
上市许可持有人
Adamed Pharma S.A. Poland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Austria (AT)
Ramipril/Amlodipin Genericon 10 mg/5 mg Hartkapseln
Italy (IT)
Greece (GR)
AMLOPRIL
Poland (PL)
Ramizek Combi
Cyprus (CY)
AMLOPRIL HARD CAPS
Czechia (CZ)
Ramizek 10 + 5 mg tvrdá tobołka
Romania (RO)
RAMIPRIL/AMLODIPINA ADAMED
Bulgaria (BG)
许可日期
2014/05/14
最近更新日期
2024/08/05
药物ATC编码
C09BB07 ramipril and amlodipine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Fixed combination Art 10b Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR Summary
|
SE/H/1336/004_PAR Summary
Date of last change:2015/01/16
PAR
|
SE/H/1336/004_PAR
Date of last change:2014/08/18
Final PL
|
SE/H/1336/004_Final PL
Date of last change:2014/07/03
Final SPC
|
SE/H/1336/004_Final SPC
Date of last change:2014/07/03
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase